113 related articles for article (PubMed ID: 27053500)
1. The Incidence and Risk of Biochemical Recurrence Following Radical Radiotherapy for Prostate Cancer in Men on Angiotensin-Converting Enzyme Inhibitors (ACEIs) or Angiotensin Receptor Blockers (ARBs).
Alashkham A; Paterson C; Windsor P; Struthers A; Rauchhaus P; Nabi G
Clin Genitourin Cancer; 2016 Oct; 14(5):398-405. PubMed ID: 27053500
[TBL] [Abstract][Full Text] [Related]
2. Association of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers with risk of mortality, severity or SARS-CoV-2 test positivity in COVID-19 patients: meta-analysis.
Biswas M; Kali MSK
Sci Rep; 2021 Mar; 11(1):5012. PubMed ID: 33658619
[TBL] [Abstract][Full Text] [Related]
3. CT visual quantitative evaluation of hypertensive patients with coronavirus disease (COVID-19): Potential influence of angiotensin converting enzyme inhibitors / angiotensin receptor blockers on severity of lung involvement.
Samanci C; Saylan B; Gulsen G; Akkaya Y; Yesildal M; Akkaya Isik S; Ustabasioglu FE
Clin Exp Hypertens; 2021 May; 43(4):341-348. PubMed ID: 33583283
[TBL] [Abstract][Full Text] [Related]
4. The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines.
Alcocer LA; Bryce A; De Padua Brasil D; Lara J; Cortes JM; Quesada D; Rodriguez P
Am J Cardiovasc Drugs; 2023 Nov; 23(6):663-682. PubMed ID: 37668854
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study.
Wu HY; Peng CL; Chen PC; Chiang CK; Chang CJ; Huang JW; Peng YS; Tu YK; Chu TS; Hung KY; Chien KL
PLoS One; 2017; 12(5):e0177654. PubMed ID: 28505194
[TBL] [Abstract][Full Text] [Related]
6. Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for Hypertension.
Graham DJ; Izurieta HS; Muthuri SG; Zhang D; Sandhu AT; Lu Y; Zhao Y; Feng Y; Eworuke E; Lyu H; Gandotra C; Smith ER; Avagyan A; Wernecke M; Kelman JA; Forshee RA; MaCurdy TE
J Gen Intern Med; 2021 Dec; 36(12):3802-3809. PubMed ID: 34599472
[TBL] [Abstract][Full Text] [Related]
7. Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan.
Huang SH; Hsu CN; Yu SH; Cham TM
BMC Public Health; 2012 May; 12():288. PubMed ID: 22521158
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin Receptor Blockade Improves Cardiac Surgical Outcomes in Patients With Metabolic Syndrome.
Manning MW; Cooter M; Mathew J; Alexander J; Peterson E; Ferguson TB; Lopes R; Podgoreanu M
Ann Thorac Surg; 2017 Jul; 104(1):98-105. PubMed ID: 28131423
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on anemia in patients with normal or mildly low glomerular filtration rate.
Ergün B; Aybal Kutlugün A; Ergün MÇ; Aktürk G; Beyan E
Turk J Med Sci; 2021 Dec; 51(6):3047-3052. PubMed ID: 34519192
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary adverse drug event data in hypertension with implications on COVID-19 morbidity.
Jaberi-Douraki M; Meyer E; Riviere J; Gedara NIM; Kawakami J; Wyckoff GJ; Xu X
Sci Rep; 2021 Jun; 11(1):13349. PubMed ID: 34172790
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin receptor blockers, but not angiotensin-converting enzyme inhibitors, inhibit abnormal bone changes in spondyloarthritis.
Choi JS; Kim JY; Ahn MJ; Jang H; Song S; Choi SH; Park YS; Jo S; Kim TH; Shim SC
Exp Mol Med; 2023 Nov; 55(11):2346-2356. PubMed ID: 37907743
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II Receptor Blockers Cause Changes in Prostate-specific Antigen Levels: A Retrospective Cohort Study.
Maeda-Minami A; Nishikawa T; Ishikawa H; Mutoh M; Makishima Y; Matsuyama Y; Akimoto K; Mano Y; Uemura H
Anticancer Res; 2023 Dec; 43(12):5629-5636. PubMed ID: 38030194
[TBL] [Abstract][Full Text] [Related]
13. Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes.
Colbourne L; Luciano S; Harrison PJ
Transl Psychiatry; 2021 May; 11(1):319. PubMed ID: 34039956
[TBL] [Abstract][Full Text] [Related]
14. Impact of ACEIs and ARBs-related adverse drug reaction on patients' clinical outcomes: a cohort study in UK primary care.
Insani WN; Whittlesea C; Ju C; Man KK; Adesuyan M; Chapman S; Wei L
Br J Gen Pract; 2023 Nov; 73(736):e832-e842. PubMed ID: 37783509
[TBL] [Abstract][Full Text] [Related]
15. Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study.
Miura R; Okada K
Hypertens Res; 2023 Dec; 46(12):2593-2602. PubMed ID: 37463982
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 morbidity and mortality associated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers use among 14,129 patients with hypertension from a US integrated healthcare system.
An J; Zhou H; Wei R; Luong TQ; Gould MK; Mefford MT; Harrison TN; Creekmur B; Lee MS; Sim JJ; Brettler JW; Martin JP; Ong-Su AL; Reynolds K
Int J Cardiol Hypertens; 2021 Jun; 9():100088. PubMed ID: 34155486
[TBL] [Abstract][Full Text] [Related]
17. Prescribing Trends of Renin-Angiotensin System Inhibitors and Mortality among Acute Coronary Syndrome Patients: Insights from the Malaysian National Cardiovascular Disease Registry.
Suki SZ; Zuhdi ASM; Yahya A; Adnan WAHWM; Zaharan NL
Saudi J Med Med Sci; 2024; 12(2):145-152. PubMed ID: 38764563
[TBL] [Abstract][Full Text] [Related]
18. Blockers of Angiotensin Other Than Olmesartan in Patients With Villous Atrophy: A Nationwide Case-Control Study.
Mårild K; Lebwohl B; Green PH; Murray JA; Ludvigsson JF
Mayo Clin Proc; 2015 Jun; 90(6):730-7. PubMed ID: 26046408
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with longer survival among older medicare patients after diagnosis of supratentorial primary brain malignancies: a retrospective cohort study.
Nguyen AV; Soto JM; Digbeu BD; Nguyen CY; Wu E; Huang JH; Kuo YF
Neurol Res; 2024 May; 46(5):379-390. PubMed ID: 38415699
[TBL] [Abstract][Full Text] [Related]
20. Impact of multiple cardiovascular medications on mortality after an incidence of ischemic stroke or transient ischemic attack.
Ma TT; Wong ICK; Whittlesea C; Man KKC; Lau W; Wang Z; Brauer R; MacDonald TM; Mackenzie IS; Wei L
BMC Med; 2021 Feb; 19(1):24. PubMed ID: 33530992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
